Over the years, Affymetrix has strived to provide and develop innovation in scientific technology by expanding her leadership portfolio in internal development, growth and strategic acquisition of businesses that are strategic to its growth plan.
Past acquisitions:
The expansion of its portfolio has been through strategic acquisition that includes: In 2000, It acquired two businesses, Genetic Systems Inc, a Massachusetts based DNA array technology instrumentation privately held business and Neomorphic Inc, a computational genomics company (Affymetrix.com, 2013). In 2005, it acquired ParAllele Bioscience Inc, a highly scalable technology for comprehensive genetic studies. In 2007, Affymetrix acquired USB corporation including its subsidiary Anatrace Inc, Ohio based company that deals with developing, manufacturing and marketing a broad range of molecular biology and biochemical reagents product for $ 75 million. The acquisition accelerated its product portfolio development and the expansion of genetic analyses. In 2008, it acquired Panomics Inc, a Fremont, California based company for $73 million (Affymetrix.com, 2013). Panomics Inc offers a suite of assay products for low a mild-plex genetic protein and cellular analysis applications and opened a downstream market opportunity whole genome analysis. And in 2012, it acquired San Diego, California based eBioscience Holdings Company, a world leader in flow cytometry and immunoassay reagents for immunology and oncology research and diagnosis for $315 million. This provided Affymetrix a world leadership product portfolio in the supply of a selection of Antibodies, ELISA, protein for life science research and diagnostics (Affymetrix.com, 2013).
Future Acquistions
Affymetrix strategic positioning and market share consolidation, it intends to acquire two strategic businesses that are involved in designing and manufacturing of injection-molding plastics that will eventually replace the GeneChip quartz base whose cost of materials is high and unsustainable (Affymetrix.com, 2013). The acquisition will offer an opportunity to invest in an automated production system that is cheaper, efficient and thus will reduce the operation cost and reduce the cost of raw materials required for the manufacturing of GeneChip quartz base (Affymetrix, 2013).
With the ever unpredictable oil prices which have increased the shipping cost, and increase in the wage bill for the operation in the Singapore manufacturing campus, it's worth reviewing and assessing the long term strategic manufacturing plan to be done locally in the USA. In acquiring this business therefore, Affymetrix will lay a long term positioning
